monoclonal antibody
Bevacizumab
Treats a cancer. This molecule appears in 301 of the medicines we have indexed.
Do you need a supplement? No.
No supplement is warranted with this treatment. A varied diet remains the foundation.
Do you also take another treatment?
By the Layer Nutrition editorial teamHow the atlas classifies the 664 molecules
- Class
- monoclonal antibody anticancer
- Indexed medicines
- 301
- Our answer
- Nothing to add
- Updated
- October 2026
What this medicine is for
This molecule belongs to the “monoclonal antibody (anticancer)” category. This medicine belongs to the “Other fields” field. Its indication is precise and set by the prescription.
In practice: Treats a cancer. How to use it is decided case by case with the professional who prescribes it.
The name on your box may be here.
These names come from the public registers of 32 countries: the ANSM for France, the AEMPS for Spain, the AIFA for Italy, the HPRA for Ireland, Swissmedic for Switzerland, and the European Medicines Agency for the others.
Most widespread
- ABEVMY
- AVASTIN
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
- AYBINTIO
- ALYMSYS
- AVZIVI
- LYTENAVA
No name matches.
See all names, country by countryHide the list by country
France6
- ABEVMY
- AVASTIN
- AYBINTIO
- MVASI
- VEGZELMA
- ZIRABEV
Germany10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Spain8
- ABEVMY
- ALYMSYS
- AVASTIN
- AYBINTIO
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Italy9
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
United Kingdom1
- OYAVAS
Ireland10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Switzerland7
- ABEVMY
- AVASTIN
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
- BEVACIZUMAB-TEVA
Austria10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Belgium10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Bulgaria10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Cyprus10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Croatia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Denmark10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Estonia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Finland10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Greece10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Hungary10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Iceland10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
- AYBINTIO
Latvia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Liechtenstein10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- LYTENAVA
- OYAVAS
- VEGZELMA
- ZIRABEV
- AYBINTIO
- MVASI
Lithuania10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Luxembourg10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Malta10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Norway10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
- AYBINTIO
Netherlands10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Poland10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Portugal10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Romania10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Slovakia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Slovenia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Sweden10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
Czechia10
- ABEVMY
- ALYMSYS
- AVASTIN
- AVZIVI
- AYBINTIO
- LYTENAVA
- MVASI
- OYAVAS
- VEGZELMA
- ZIRABEV
One answer out of three.
The atlas gives each molecule one of these three answers. Most call for nothing.
- Our formula31 molecules
- An active ingredient to consider59 molecules
- Nothing to add574 moleculesincluding this one
Do you also take another treatment?
Type the name written on the box. The atlas gives you its answer.
For example Panadol, Doliprane or paracetamol.